Mulmit

HUTCHMED (China) LtdHUTCHMED (China) Ltd

HCM Nasdaq

Annual financials

PeriodRevenueOperating incomeNet incomeEPS
2025-12-31548,512,000-39,160,000456,909,0000.52
2024-12-31630,201,000-43,705,00037,729,0000.04
2023-12-31837,999,00018,375,000100,780,0000.12
2022-12-31426,409,000-407,693,000-360,835,000-0.43
2021-12-31356,128,000-328,317,000-194,648,000-0.25

Insider filings (Forms 3/4/5)

DateOwnerTitleShares
2026-05-20Cheng Chig FungActing CEO and CFO30,157
2026-05-20Cheng Chig FungActing CEO and CFO26,307
2026-05-20Nixon Charles George RupertGroup General Counsel7,445
2026-05-20Nixon Charles George RupertGroup General Counsel7,644
2026-05-20Su Wei-guoCEO and CSO132,864
2026-05-20Su Wei-guoCEO and CSO75,140
2026-05-20Chiu LorensoDeputy Chief Financial Officer5,176
2026-05-20Chiu LorensoDeputy Chief Financial Officer8,863
데이터를 불러오는 중입니다…Loading…

가격 차트Price chart

차트를 불러오는 중입니다…Loading chart…

Pharmaceutical Preparations — 같은 업종, 그리고 규모가 비슷한 기업Pharmaceutical Preparations — and other companies of a similar size

SEC가 같은 업종(Pharmaceutical Preparations)으로 분류한 기업이 먼저 오고, 그다음은 제출된 매출로 가까운 순입니다 — 가장 최근 연간 값이며, 연간 값이 없으면 최근 네 분기 합입니다. Companies the SEC assigns to the same industry (Pharmaceutical Preparations) come first, then the nearest by revenue as filed — the latest annual figure, or the last four quarters where no annual one is filed. 순서일 뿐 값이 싸거나 비싸다는 뜻이 아닙니다.Order only — it does not say a company is cheap or expensive.